T7	Subject 80 106	56-year-old female patient
T10	Treatment 22 38	arsenic trioxide
T11	Age 80 91	56-year-old
T12	Gender 92 98	female
T13	Drug 22 38	arsenic trioxide
T15	Treat-Disorder 122 153	chemotherapy/ATRA-resistant APL
T14	Duration 67 74	42 days
T9	Potential_therapeutic_event 43 48	given
E1	Potential_therapeutic_event:T9